• Je něco špatně v tomto záznamu ?

Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One-Centre experience with TDM

M. Mieresova, K. Balazova, J. Kubele, D. Cerny, M. Halacova

. 2023 ; 11 (3) : e7032. [pub] 20230311

Status neindexováno Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu kazuistiky

Perzistentní odkaz   https://www.medvik.cz/link/bmc23002697

The aim of this article is to demonstrate extreme interindividual variability of piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients and to emphasize the need for the practice of routine PIP/TAZO plasma concentrations measurement in order to ensure optimal efficacy and safety of antibiotic therapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23002697
003      
CZ-PrNML
005      
20230421100046.0
007      
ta
008      
230413s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ccr3.7032 $2 doi
035    __
$a (PubMed)36919150
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Mieresova, M $u Department of Clinical Pharmacy Na Homolce Hospital Prague Czech Republic $u Department of Pharmacology Motol University Hospital and 2nd Faculty of Medicine, Charles University Prague Czech Republic
245    10
$a Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One-Centre experience with TDM / $c M. Mieresova, K. Balazova, J. Kubele, D. Cerny, M. Halacova
520    9_
$a The aim of this article is to demonstrate extreme interindividual variability of piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients and to emphasize the need for the practice of routine PIP/TAZO plasma concentrations measurement in order to ensure optimal efficacy and safety of antibiotic therapy.
590    __
$a NEINDEXOVÁNO
655    _2
$a kazuistiky $7 D002363
700    1_
$a Balazova, K $u Department of Clinical Pharmacy Na Homolce Hospital Prague Czech Republic
700    1_
$a Kubele, J $u Department of Clinical Microbiology and Antibiotic Surveillance Na Homolce Hospital Prague Czech Republic
700    1_
$a Cerny, D $u Department of Clinical Pharmacy Na Homolce Hospital Prague Czech Republic $u Institute of Pharmacology, General University Hospital and 1st Faculty of Medicine, Charles University Prague Czech Republic
700    1_
$a Halacova, M $u Department of Clinical Pharmacy Na Homolce Hospital Prague Czech Republic $u Department of Pharmacology Motol University Hospital and 2nd Faculty of Medicine, Charles University Prague Czech Republic
773    0_
$w MED00194285 $t Clinical case reports $x 2050-0904 $g Roč. 11, č. 3 (2023), s. e7032
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36919150 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230413 $b ABA008
991    __
$a 20230421100039 $b ABA008
999    __
$a ok $b bmc $g 1922633 $s 1188904
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 11 $c 3 $d e7032 $e 20230311 $i 2050-0904 $m Clinical case reports $n Clin Case Rep $x MED00194285
LZP    __
$a Pubmed-20230413

Najít záznam

Citační ukazatele

Možnosti archivace